Company intelligence / Profile preview

Tessara Therapeutics

Blackburn, Victoria, Australiatessaratherapeutics.com ↗

Ownership: Private
Development stage: Other

Overview

Tessara Therapeutics has developed the RealBrain® platform—synthetic human brain tissue models that recapitulate neurophysiology for use in drug discovery, target identification/validation, and lead compound characterization. The company’s work has enabled early collaborations with pharmaceutical partners and attracted seed funding of AUD $2.7M to accelerate neurological disease research. No direct clinical results reported as the focus remains on enabling technologies for preclinical R&D.

Therapeutic areas: Neurology
Modalities: Induced pluripotent stem cell derived therapyCell therapyDevice
Industry: Non-Drug Biotech

Partnerships

CSIRO Kick-start program collaboration for biomaterials optimization and manufacturing scale-up

Beyond the preview

Go deeper on Tessara Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tessara Therapeutics.

Explore the full profile